Martin Vladimirov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Martin Vladimirov has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Bozhidar Karamishev
Faculty of Medicine, Medical University-Sofia, 1431 Sofia, Bulgaria
2 shared publications - Daria Koleva
Faculty of Medicine, Medical University-Sofia, 1431 Sofia, Bulgaria
2 shared publications - Liliya Koleva
Clinic of Operative Gynecology, University Hospital “Pirogov”-Sofia, 1606 Sofia, Bulgaria
2 shared publications - Vesela Karamisheva
Medical University of Sofia and University Hospital of Obstetrics and Gynecology “Maichin dom”, Bulgaria
2 shared publications A Kolev
Faculty of Medicine, Medical University – Sofia , Sofia , Bulgaria
1 shared publication- Anatoli Kolev
Faculty of Medicine, Medical University-Sofia, 1431 Sofia, Bulgaria
1 shared publication
Latest Publications
- Open Access
- 14 July 2026
- Published by IntechOpen
Perspective Chapter: Endometriosis – Challenges in Diagnosis and Treatment – Status and Future Perspectives
Endometriosis (EM) is a chronic, estrogen-dependent, inflammatory disease characterized by the presence of endometrial-like tissue outside the uterus. It is estimated that EM occurs in approximately 10% of women of the reproductive age and is associated with severe morbidity in the form of chronic pelvic pain and subfertility. Diagnosis is challenging due to nonspecific symptoms, long diagnosis-to-treatment times (4–11 years), the inability of imaging techniques to accurately locate superficial lesions, and the lack of validated noninvasive biomarkers. The latest European Society of Human Reproduction and Embryology (ESHRE) and American College of Obstetricians and Gynecologists (ACOG) guidelines no longer consider laparoscopy as the reference standard test. Presently, the management of EM is focused on symptom control using hormones (such as combined oral contraceptives, progestins, and gonadotropin-releasing hormone analogs) and surgery in non-responders or for fertility preservation. However, EM is highly recurrent, with recurrence rates of up to 50% at five years after treatment, associated with numerous side effects and limited improvement in fertility preservation rates. Precision medicine for EM will require the identification of multiomic biomarkers of the disease to develop non-invasive approaches for the diagnosis and management of EM using artificial intelligence-based imaging technologies and novel immunomodulatory drugs.
- 14 July 2026
- Published by IntechOpen
Open AccessPerspective Chapter: Endometriosis – Challenges in Diagnosis and Treatment – Status and Future Perspectives
Endometriosis (EM) is a chronic, estrogen-dependent, inflammatory disease characterized by the presence of endometrial-like tissue outside the uterus. It is estimated that EM occurs in approximately 10% of women of the reproductive age and is associated with severe morbidity in the form of chronic pelvic pain and subfertility. Diagnosis is challenging due to nonspecific symptoms, long diagnosis-to-treatment times (4–11 years), the inability of imaging techniques to accurately locate superficial lesions, and the lack of validated noninvasive biomarkers. The latest European Society of Human Reproduction and Embryology (ESHRE) and American College of Obstetricians and Gynecologists (ACOG) guidelines no longer consider laparoscopy as the reference standard test. Presently, the management of EM is focused on symptom control using hormones (such as combined oral contraceptives, progestins, and gonadotropin-releasing hormone analogs) and surgery in non-responders or for fertility preservation. However, EM is highly recurrent, with recurrence rates of up to 50% at five years after treatment, associated with numerous side effects and limited improvement in fertility preservation rates. Precision medicine for EM will require the identification of multiomic biomarkers of the disease to develop non-invasive approaches for the diagnosis and management of EM using artificial intelligence-based imaging technologies and novel immunomodulatory drugs.
- Open Access
- 1 July 2026
- Published by Walter de Gruyter GmbH in Balkan Journal of Medical Genetics
- Vol. 29 (1) , 1-6
Plasma Microrna Profiling in Overweight and Obese Pregnant Women: An Exploratory Pooled-Sample Study
Background: Maternal overweight and obesity are associated with metabolic, vascular, and obstetric complications. Circulating microRNAs (miRNAs) are stable in plasma and may reflect obesity-related molecular alterations during pregnancy. Aim: To compare plasma miRNA expression profiles between normal-weight and overweight/obese pregnant women. Methods: The study included 50 pregnant women: 25 with normal weight and 25 with overweight/obesity. RNA was isolated from individual plasma samples and combined into one pooled RNA sample per study group. The pooled samples were analyzed in technical triplicate using a 96-well miRCURY LNA PCR panel containing 84 target miRNA assays and quality-control/reference assays. Results: Seventeen target miRNAs met the predefined >2-fold higher-expression threshold and 15 met the <0.5-fold threshold in the over-weight/obese pool. miR-21-5p was the only target miRNA that met both the predefined twofold magnitude criterion and the nominal p < 0.05 threshold (fold change = 2.58; p = 0.030266). Conclusion: The pooled-sample analysis identifies miR-21-5p as an exploratory candidate signal associated with maternal overweight/obesity. Individual-sample testing and validation in larger independent cohorts are required before biomarker performance or clinical utility can be established.
- 1 July 2026
- Published by Walter de Gruyter GmbH in Balkan Journal of Medical Genetics
- Vol. 29 (1) , 1-6
Open AccessPlasma Microrna Profiling in Overweight and Obese Pregnant Women: An Exploratory Pooled-Sample Study
Background: Maternal overweight and obesity are associated with metabolic, vascular, and obstetric complications. Circulating microRNAs (miRNAs) are stable in plasma and may reflect obesity-related molecular alterations during pregnancy. Aim: To compare plasma miRNA expression profiles between normal-weight and overweight/obese pregnant women. Methods: The study included 50 pregnant women: 25 with normal weight and 25 with overweight/obesity. RNA was isolated from individual plasma samples and combined into one pooled RNA sample per study group. The pooled samples were analyzed in technical triplicate using a 96-well miRCURY LNA PCR panel containing 84 target miRNA assays and quality-control/reference assays. Results: Seventeen target miRNAs met the predefined >2-fold higher-expression threshold and 15 met the <0.5-fold threshold in the over-weight/obese pool. miR-21-5p was the only target miRNA that met both the predefined twofold magnitude criterion and the nominal p < 0.05 threshold (fold change = 2.58; p = 0.030266). Conclusion: The pooled-sample analysis identifies miR-21-5p as an exploratory candidate signal associated with maternal overweight/obesity. Individual-sample testing and validation in larger independent cohorts are required before biomarker performance or clinical utility can be established.
- Open Access
Specific IgE/IgG in Umbilical Cord Blood and Maternal Blood in Mothers with Eosinophilia
Background: Presence of milk, fruits, eggs, fish, nuts and wheat antigens in the amniotic fluid is described in the literature. Studies show a contradictory relationship between maternal exposure to allergens and early sensitization of the fetus to allergens. Hemochorionic type of the human placenta allows for easier transfer of nutrients and antibodies from the mother’s blood to the fetal circulation through the direct contact of maternal blood with the fetal chorion. During the third trimester of pregnancy, immunoglobulin G (IgG) is actively transferred through the placenta into the fetal via neonatal FcRN receptor (FcRN). In addition, monomeric immunoglobulin E (IgE) cannot cross the placenta Aim: The objective of our study is to track intrauterine sensitization to essential food proteins at birth in umbilical cord blood in mothers with established peripheral blood eosinophilia and in their infants using allergen-specific IgE and IgG. Methods: An observational study was carried out in a cohort of 22 mothers with eosinophilia and their babies. Differences in expression between groups were assessed. Blood samples were collected to determine serum IgE and IgG specific to a set of inhalant and food allergens. Results: We did not find a significant correlation between specific IgE to cow’s milk (p = 0.857), egg white (p = 0.926) and egg yolk (p = 0.096) in umbilical cord blood and maternal blood samples taken immediately before birth. Spearman’s correlation of the specific IgE and IgG in umbilical cord blood showed no dependence between the two variables. In contrast, statistical analysis showed that maternal eosinophilia in peripheral blood could be a risk factor for the development of allergy in the offspring (χ2, p = 0.0347). However, given the small number of patients, this claim needs to be confirmed with further studies. Conclusions: Due to the functional immaturity of the developing immune system of the fetus, the generation and maintenance of an independent immune response to allergens are incomplete. Maternal IgG (specific) passes to the baby and high maternal IG to a specific allergen reduces babies IgE production. In addition, low maternal specific IgG may promote IgE production in the baby under the influence of microenvironmental factors (cytokine background). The main limitation of our study is the small number of patients. Further research is needed in this direction to clarify the mechanisms and risk factors for early sensitization in newborns.
Open AccessSpecific IgE/IgG in Umbilical Cord Blood and Maternal Blood in Mothers with Eosinophilia
Background: Presence of milk, fruits, eggs, fish, nuts and wheat antigens in the amniotic fluid is described in the literature. Studies show a contradictory relationship between maternal exposure to allergens and early sensitization of the fetus to allergens. Hemochorionic type of the human placenta allows for easier transfer of nutrients and antibodies from the mother’s blood to the fetal circulation through the direct contact of maternal blood with the fetal chorion. During the third trimester of pregnancy, immunoglobulin G (IgG) is actively transferred through the placenta into the fetal via neonatal FcRN receptor (FcRN). In addition, monomeric immunoglobulin E (IgE) cannot cross the placenta Aim: The objective of our study is to track intrauterine sensitization to essential food proteins at birth in umbilical cord blood in mothers with established peripheral blood eosinophilia and in their infants using allergen-specific IgE and IgG. Methods: An observational study was carried out in a cohort of 22 mothers with eosinophilia and their babies. Differences in expression between groups were assessed. Blood samples were collected to determine serum IgE and IgG specific to a set of inhalant and food allergens. Results: We did not find a significant correlation between specific IgE to cow’s milk (p = 0.857), egg white (p = 0.926) and egg yolk (p = 0.096) in umbilical cord blood and maternal blood samples taken immediately before birth. Spearman’s correlation of the specific IgE and IgG in umbilical cord blood showed no dependence between the two variables. In contrast, statistical analysis showed that maternal eosinophilia in peripheral blood could be a risk factor for the development of allergy in the offspring (χ2, p = 0.0347). However, given the small number of patients, this claim needs to be confirmed with further studies. Conclusions: Due to the functional immaturity of the developing immune system of the fetus, the generation and maintenance of an independent immune response to allergens are incomplete. Maternal IgG (specific) passes to the baby and high maternal IG to a specific allergen reduces babies IgE production. In addition, low maternal specific IgG may promote IgE production in the baby under the influence of microenvironmental factors (cytokine background). The main limitation of our study is the small number of patients. Further research is needed in this direction to clarify the mechanisms and risk factors for early sensitization in newborns.